About SC Oncolab SRL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Boehringer Ingelheim
2
Puma Biotechnology, Inc.
2
Bayer
1
BeiGene
1
Biocad
1
Can-Fite BioPharma
1
Canadian Cancer Trials Group
1
Clovis Oncology, Inc.
1
Daiichi Sankyo, Inc.
1
Gilead Sciences
1
Clinical Trials at SC Oncolab SRL
During the past decade, SC Oncolab SRL conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on
average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
2009-08-14
2017-03-16
Completed
345
Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.
2009-12-16
2020-06-19
Completed
99
IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
2010-12-01
2015-07-01
Completed
339
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SC Oncolab SRL" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "BeiGene"
with 1 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SC Oncolab SRL"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at SC Oncolab SRL
According to Clinical.Site data, the most researched conditions in "SC Oncolab SRL" are
"Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Advanced or Inoperable Gastric Cancer" (1 trials). Many other conditions were trialed in "SC Oncolab SRL" in a lesser frequency.
Clinical Trials Intervention Types at SC Oncolab SRL
Most popular intervention types in "SC Oncolab SRL" are "Drug" (22 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (4 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SC Oncolab SRL
The vast majority of trials in "SC Oncolab SRL" are
16 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at SC Oncolab SRL
Currently, there are NaN active trials in "SC Oncolab SRL".
1 are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in SC Oncolab SRL,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SC Oncolab SRL, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".